The United States Food and Drug Administration (FDA) recently released a draft guidance, Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics. Accelerated approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
